Tech Company Financing Transactions
DARA Biosciences Funding Round
On 3/31/2006, DARA Biosciences raised $10.3 million in funding from Clayton Associates.
Transaction Overview
Company Name
Announced On
3/31/2006
Transaction Type
Venture Equity
Amount
$10,256,000
Round
Undisclosed
Investors
Clayton Associates (Stuart McWhorter)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
8601 Six Forks Rd. 160
Raleigh, NC 27615
USA
Raleigh, NC 27615
USA
Phone
Website
Email Address
Overview
DARA is a pharmaceutical company commercializing treatments and supportive care products for oncology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Drutz
Chief Financial Officer
David Tousley
Chief Operating Officer
Christopher Clement
VP - Bus. Development
David Benharris
VP - Regulatory Affairs
Mary Delmedico
VP - Sales
Len Tenzer
Browse more venture capital transactions:
Prev: 3/31/2006: Market Velocity venture capital transaction
Next: 3/31/2006: US Renal Care venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to record tech company VC transactions. VC transactions on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs